Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Novo Nordisk Testing Pill Version of Ozempic, Wegovy for Weight Loss Many participants reported similar gastrointestinal side effects as those linked to Ozempic and Wegovy when using the proposed weight loss pill. September 18, 2024 Irvin Jackson Add Your Comments Novo Nordisk is in the process of conducting clinical trials on a pill version of Wegovy, a weight loss drug that contains the same active ingredient as the diabetes treatment Ozempic, in hopes of drawing in more potential consumers with a non-injectable version of the medication. Last week, Novo Nordisk presented early clinical trial data (PDF) on Amycretin, an experimental daily weight loss pill, which works similarly to Ozempic and Wegovy, as a glucagon-like peptide-1 (GLP-1) receptor agonist, but also includes pancreas hormones that reduce feelings of hunger and does not require a weekly shot. The drug maker indicated that participants receiving the proposed diet pill experienced significant reduction in body weight after three months of use, according to a presentation at the European Association for the Study of Diabetes. The diet pill is the latest effort by the manufacturer to capitalize on the success of Ozempic, which is marketed for treatment of diabetes, but has become one of the top-selling drugs in the U.S. based on “off-label” use as a diet drug. Given the effectiveness of Ozempic promoting weight loss, Novo Nordisk previously introduced Wegovy in 2021, which contains the same active ingredient, semaglutide, but is specifically approved by the FDA for weight loss. Although the drugs have been aggressively marketed as safe and effective, Novo Nordisk now faces a growing number of Ozempic lawsuits and Wegovy lawsuits being filed by users left with devastating long-term gastrointestinal problems, like gastroparesis or bowel obstructions, claiming that the drug maker placed a desire for profits before consumer safety by withholding information about the potential side effects. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Currently, both Ozempic and Wegovy are introduced to the body through injections, which gives some consumers pause. However, Novo Nordisk hopes a daily pill like Amycretin will pull in those who may be squeamish about regularly sticking themselves with needles. The company indicates that it has conducted a phase 1 clinical trial which found that Amycretin users lost more than 13% of their body weight in only three months. However, the drug also showed signs of similar gastrointestinal side effects as Ozempic and Wegovy, including nausea and vomiting. The trial involved 60 participants, and there was only one serious adverse event reported. However, users reported about 242 mild or moderate complications with Amycretin, largely involving gastrointestinal side effects also linked to Ozempic and Wegovy. Novo Nordisk indicates the findings have cleared the way for continued testing and development of the weight loss pill. However, it is unclear when or if Amycretin will be approved for weight loss use by the U.S. Food and Drug Administration. Ozempic and Wegovy Stomach Paralysis Risks Novo Nordisk is releasing the findings amid growing awareness among consumers and the medical community about the risk of gastroparesis from Wegovy, Ozempic and similar drugs when used for weight loss, which could erode sales as more users learn about the potential side effects. Gastroparesis, also known as delayed gastric emptying or stomach paralysis, weakens the normal muscle movement in the stomach. These stomach contractions are necessary to push food through the digestive tract. When gastroparesis occurs, the stomach is slow to empty, resulting in symptoms including nausea, vomiting undigested food, abdominal pain, abdominal bloating, severe dehydration, feeling full after only a few bites, undigested food hardening in the stomach, acid reflux, fluctuating blood sugar levels, lack of appetite, weight loss, malnutrition and decreased quality of life. However, some users are reporting these side effects persist long after Wegovy or Ozempic are discontinued. September 2024 Ozempic and Wegovy Lawsuits Update Given common questions of fact and law raised in complaints filed throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established coordinated pretrial proceedings for all Ozempic, Wegovy and other GLP-1 lawsuits earlier this year, transferring complaints to the U.S. District Court for the Eastern District of Pennsylvania, where U.S. District Judge Karen S. Marston is presiding over coordinated discovery. As part of the management of the MDL, Judge Marston has indicated that before any individual cases are prepared for trial, the Court will address a number of “cross cutting” issues in the litigation, which may impact a large number of claims. Therefore, early discovery and motions will focus on addressing whether the claims are pre-empted by federal law, and whether plaintiffs must provide specific gastroparesis diagnostic testing evidence in the Ozempic and Wegovy lawsuits. In addition, the court is still considering whether the first phase of discovery will also include an examination of the general evidence that Ozempic and Wegovy cause stomach paralysis, or whether challenges to the admissibility of expert witness testimony will be addressed during the work up of individual bellwether claims for trial. Tags: Bowel Obstruction, Clinical Trials, Gastroparesis, Novo Nordisk, Ozempic, Stomach Paralysis, Wegovy, Weight Loss Pill Image Credit: MOLEQL Find Out If You Qualify for Ozempic or Wegovy Compensation More Ozempic, Wegovy and Mounjaro Lawsuit Stories Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court June 18, 2025 Saxenda, Wegovy Vision Loss Lawsuit Filed Over NAION Diagnosis June 13, 2025 Ozempic NAION Side Effects Result in Vision Loss Warnings by European Regulators June 9, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: today) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 2 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 3 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: today) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 2 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 3 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)